Christopher Barbieri, M.D., Ph.D


Locations and Appointments

Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

*Indicates this doctor is no longer accepting new patients with this insurance plan.

  • HMO
  • Medicare
  • PPO
  • CHP
  • Blue Access
  • Blue Connection
  • EPO
  • HMO
  • Mediblue (Senior)
  • PPO
  • CBP
  • Medicaid
  • Medicare
  • Freedom
  • Liberty
  • Medicare Advantage
  • Metro/Core/Charter
  • Community Plan
  • Medicare
  • HMO
  • Medicare
Personal Statement

Prostate cancer is a disease with highly variable outcomes - many patients have slow growing cancers that will never threaten their health, while other have aggressive cancers that may rapidly progress.  A variety of new tools are available to help urologists match the right patient with the right treatment course, from cutting edge tests exposing the molecular basis of these cancers to imaging techniques that can allow precise targeting of cancers. A urologist that understands the use and limitations of these tools is critical to get the best outcomes. I am both a prostate cancer surgeon and a highly active researcher in prostate cancer genomics in the Sandra and Edward Meyer Cancer Center at Weill Cornell, allowing me to stay at the forefront of prostate cancer care in the 21st century, and delivering the best possible care to patients at Weill Cornell.

Biographical Info

Dr. Christopher Barbieri completed both his Urology Residency and Urologic Oncology Fellowship at Weill Cornell Medical College. He received his undergraduate degree from Dartmouth College and then attended Vanderbilt University School of Medicine, where he obtained both his MD and PhD degrees. Dr. Barbieri's research interests include using genomic data to define distinct molecular subclasses of urologic malignancy, with a particular focus on prostate cancer. His work has led to recognition as a Prostate Cancer Foundation Young Investigator and a Urology Care Foundation Research Scholar; he is also the recipient of a Career Development Award from the National Cancer Institute to fund his work on prostate cancer. In addition, Dr. Barbieri has also been recognized as a Rising Star in Urology Research by the American Urological Association, and with a Clinical Investigator Award from the Damon Runyon Cancer Research Foundation. 

Dr. Barbieri sees patients seeking urologic oncology treatment. His office is located at 525 E. 68th Street, Starr Pavilion, 9th floor within the Brady Urologic Health Center.

Please call Dr. Barbieri's office at 212-746-5562 if you have any questions or would like to make an appointment.



"I have been seeing Dr. Barbieri for 2 years after being diagnosed with prostate cancer. He is extremely knowledgeable and professional. When I needed a cystoscopy the conditions and staff were excellent. The entire staff are also very professional and kind. I highly recommend Dr. Barbieri." - Fred M. via Healthgrades on July 05, 2018

"Dr. Barbieri is an outstanding surgeon and physician. He is honest and trustworthy in all his interactions. I am very happy and grateful to have found Dr. Barbieri. Competence and highly skilled are words that appropriately describe him." - Paul C. via Healthgrades on April 28, 2018

"Trust is not a word that I normally use when discussing doctors. However, I couldn't have a conversation about Dr. Barbieri without mentioning it. He is the consummate professional beyond his superior technical skills. He's a fantastic listener and a straight shooter. He has a quiet confidence, and an amazing talent for putting a patient at ease. He should also be given credit for assembling a fantastic team, and establishing a culture that makes every single visit an amazing patient experience" - Chuck R. via Healthgrades on Jun 01, 2017


Additional resources related to Dr. Barbieri's research lab, including recent publications & ongoing studies, can be found on

To learn more about Dr. Barbieri's research, please visit:

Weill Cornell Medicine VIVO

Sandra and Edward Meyer Cancer Center

Webinar - Prostate Cancer: Understand Causes, Diagnosis, and Treatment:

Board Certifications
American Board of Urology
Clinical Expertise
Prostate Cancer
Cancer of Kidney
Prostate Biopsy
Robotic Surgery
Molecular Cancer Testing
Targeted Prostate Biopsy
Precision Medicine
Elevated PSA (Prostate-Specific Antigen)
  • M.D.
    Vanderbilt University School of Medicine
  • Ph.D.
    Vanderbilt University School of Medicine
  • A.B.
    Dartmouth College
  • Associate Attending Urologist
    NewYork-Presbyterian Hospital
  • Associate Professor of Urology
    Weill Cornell Medical College, Cornell University
  • Peter M. Sacerdote Distinguished Associate Professor in Urologic Oncology
    Weill Cornell Medical College, Cornell University

We Are Weill Cornell Medicine | Dr. Christopher Barbieri

We Are Weill Cornell Medicine | Dr. Christopher Barbieri

Dr. Christopher Barbieri - Genomic Testing For Prostate Cancer Patients

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

Professional Services: 
American Urological Association
Advisory/Scientific Board Member: 
American Urological Association
Other Interest: 
National Cancer Institute
United States Department of Defense